Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura S M Kerkmeijer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 8, 2020
Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stentLaura S M Kerkmeijer, Jaya Chandrasekhar, Deborah N Kalkman, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 29, 2020
Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-studyLaura S M Kerkmeijer, Ruben Y G Tijssen, Sjoerd H Hofma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 6, 2021
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trialLaura S M Kerkmeijer, Mick P L Renkens, Ruben Y G Tijssen, et al.
Circulation. Cardiovascular Interventions|August 26, 2020
Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary InterventionHironori Hara, Kuniaki Takahashi, Norihiro Kogame, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 6, 2025
Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trialMick P L Renkens, Maik J D Grundeken, Laura S M Kerkmeijer, et al.
International Journal of Cardiology|September 13, 2019
A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trialLaura S M Kerkmeijer, Ruben Y G Tijssen, Sjoerd H Hofma, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 11, 2019
Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudyRuben Y G Tijssen, Rene J van der Schaaf, Robin P Kraak, et al.
The International Journal of Cardiovascular Imaging|January 4, 2020
The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudyRuben Y G Tijssen, Laura S M Kerkmeijer, Kuniaki Takahashi, et al.
The International Journal of Cardiovascular Imaging|March 27, 2019
The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trialRuben Y G Tijssen, Laura S M Kerkmeijer, Yuki Katagiri, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 8, 2020
Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stentLaura S M Kerkmeijer, Jaya Chandrasekhar, Deborah N Kalkman, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 29, 2020
Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-studyLaura S M Kerkmeijer, Ruben Y G Tijssen, Sjoerd H Hofma, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 6, 2021
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trialLaura S M Kerkmeijer, Mick P L Renkens, Ruben Y G Tijssen, et al.
Circulation. Cardiovascular Interventions|August 26, 2020
Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary InterventionHironori Hara, Kuniaki Takahashi, Norihiro Kogame, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 6, 2025
Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trialMick P L Renkens, Maik J D Grundeken, Laura S M Kerkmeijer, et al.
International Journal of Cardiology|September 13, 2019
A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trialLaura S M Kerkmeijer, Ruben Y G Tijssen, Sjoerd H Hofma, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 11, 2019
Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudyRuben Y G Tijssen, Rene J van der Schaaf, Robin P Kraak, et al.
The International Journal of Cardiovascular Imaging|January 4, 2020
The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudyRuben Y G Tijssen, Laura S M Kerkmeijer, Kuniaki Takahashi, et al.
The International Journal of Cardiovascular Imaging|March 27, 2019
The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trialRuben Y G Tijssen, Laura S M Kerkmeijer, Yuki Katagiri, et al.
Pageof 1